RIP
MIRM icon

Reliant Investment Partners’s Mirum Pharmaceuticals MIRM Stock Holding History

Reliant Investment Partners’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$699K Hold
5,975
– – 0.48% 48
2026
Q1 		$552K Hold
5,975
– – 0.46% 52
2025
Q4 		$472K Sell
5,975
-1,000
-14% -$71.8K 0.37% 59
2025
Q3 		$509K Hold
6,975
– – 0.4% 56
2025
Q2 		$355K Hold
6,975
– – 0.31% 83
2025
Q1 		$314K Hold
6,975
– – 0.32% 73
2024
Q4 		$288K Buy
+6,975
New +$291K 0.26% 87

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Reliant Investment Partners's MIRM Position: Q2 2026 in Review

Reliant Investment Partners held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 5,975 shares worth $699K. The position accounts for 0.48% of the portfolio, ranked #48.

Reliant Investment Partners first reported a position in MIRM in Q4 2024 and has held it in 7 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Reliant Investment Partners held 5,975 shares of Mirum Pharmaceuticals worth $699K as of Q2 2026.
  • Reliant Investment Partners left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
  • Mirum Pharmaceuticals made up 0.48% of Reliant Investment Partners's portfolio in Q2 2026, its #48 holding.
  • Reliant Investment Partners first reported a position in Mirum Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Reliant Investment Partners's 13F filing for Q2 2026, filed 11 Aug 2026.